← Leaderboards
Jinhong Chang
Baruch S. Blumberg Institute
$16,016,617
Attributed
$16,016,617
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7M · FY2018–24$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,016,617 · 2
By mechanism
N01$12,480,276 · 1
R01$3,536,341 · 1
Top collaborators
No co-investigators on record.
Most similar at Baruch S. Blumberg Institute
Same institution · by research overlap
- Haitao Guo$14,400,355
Others in their field
Other Emerging Leaders on “Viral”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$160,855,334
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,911,178
- John Damon Chodera · Sloan-Kettering Inst Can Research$51,025,260
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- Thomas Denny · Duke University$37,546,967
Research focus
ViralPre-ClinicalYellow Fever VirusYellow Fever Virus InfectionLead OptimizationYellow FeverVirus DiseasesAmino AcidsAcuteComplexAlanineAttenuatedBenzodiazepinesBindingAnti-Viral EfficacyAbsorptionClinical CandidateBody Weight DecreasedAfricaCellsCentral AmericaCessation Of LifeAreaBiological Availability
Grant awards (8)
Development of an Antiviral to Combat Viral Infections$4,020,000
N01 · FY2024 · AI · contact PI
Development of an Antiviral for Yellow Fever Virus Infection$2,966,400
N01 · FY2024 · AI · contact PI
DEVELOPMENT OF AN ANTIVIRAL FOR YELLOW FEVER VIRUS INFECTION$5,493,876
N01 · FY2023 · AI · contact PI
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever$680,797
R01 · FY2022 · AI · contact PI
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever$692,067
R01 · FY2021 · AI · contact PI
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever$716,197
R01 · FY2020 · AI · contact PI
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever$723,640
R01 · FY2019 · AI · contact PI
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever$723,640
R01 · FY2018 · AI · contact PI